Abstract Number: 2805 • 2013 ACR/ARHP Annual Meeting
Synovial Explant Inflammatory Mediator Production Is Associated With Synovitis While Not With Bone Marrow Edema In Rheumatoid Arthritis: A Cross Sectional Study
Background/Purpose: Synovitis and bone damage may represent two distinct but overlapping pathological processes in rheumatoid arthritis (RA). Whereas the bulk of synovial cells contribute to…Abstract Number: 2806 • 2013 ACR/ARHP Annual Meeting
Low Risk Of Hepatitis B Virus Surface Antigen Seroreversion In HBsAg Negative/Anti-Hbc Positive Carriers Undergoing Rituximab For Rheumatoid Arthritis
Background/Purpose: B cell-targeted therapy using rituximab (RTX), anti-CD20 monoclonal antibody, is an effective treatment for Rheumatoid arthritis (RA). However, the safety of such therapy in…Abstract Number: 2807 • 2013 ACR/ARHP Annual Meeting
Management Of Vertebral Osteomyelitis: A Randomized Clinical Trial Comparing 6 Versus 12 Weeks Of Antibiotic Treatment
Background/Purpose: As for most of bone and joint infection, optimal treatment duration for vertebral osteomyelitis (VO) is unknown. In an era of increasing bacterial resistance,…Abstract Number: 2808 • 2013 ACR/ARHP Annual Meeting
Favorable Outcome Of Hepatitis E Virus Infection In Patients With Inflammatory Arthritides Treated With Immunosupressants
Background/Purpose: In inflammatory rheumatic diseases, the prevalence, clinical presentation and outcome of hepatitis E, an ubiquitous viral infection, remain unknown. We therefore addressed these issues…Abstract Number: 2809 • 2013 ACR/ARHP Annual Meeting
Prevalence and Clinical Presentation Of Lyme Arthritis In a Large Cohort Of Patients With Recent-Onset Arthritis
Background/Purpose: Lyme arthritis is a relatively uncommon form of arthritis that is relevant to identify because it requires specific therapy. The presents study aimed to…Abstract Number: 2810 • 2013 ACR/ARHP Annual Meeting
Follow-Up Testing Of Interferon-Gamma Release Assays For The Diagnosis Of Hidden Tuberculosis Infection In Patients Receiving Tumor Necrosis Factor Alpha Antagonists
Background/Purpose: Anti-tumor necrosis factor alpha (Anti-TNFα) therapy is often used in patients with rheumatic diseases who do not respond to conventional treatment. Risk of tuberculosis…Abstract Number: 2811 • 2013 ACR/ARHP Annual Meeting
Disease Characteristics and Treatment Patterns In US Veterans With Rheumatoid Arthritis and Concomitant Hepatitis C Infection
Background/Purpose: The prevalence of concurrent rheumatoid arthritis (RA) and hepatitis C (HCV) is estimated at 0.02%, affecting around 40,000 Americans. To our knowledge, no existing…Abstract Number: 2812 • 2013 ACR/ARHP Annual Meeting
A Rheumatology Objective Structured Clinical Examination Using Challenging Patient Scenarios Shows Trainee Use Of Medical Jargon Correlates Inversely With Patient Perceptions Of Professionalism
Background/Purpose: For 8 years, the New York City Rheumatology Objective Self Assessment Clinical Exam (NYC-ROSCE) has been used to assess trainee competencies such as patient…Abstract Number: 2813 • 2013 ACR/ARHP Annual Meeting
Expert Panel Consensus On Content Of a Rheumatology Objective Structured Clinical Examination
Background/Purpose: Rheumatology objective structured clinical examinations (ROSCEs) are assessment tools to evaluate learner performance in simulated clinical experiences. ROSCEs allow standardization of learner assessment…Abstract Number: 2814 • 2013 ACR/ARHP Annual Meeting
The Resident-Fellow Interaction: Limiting Barriers and Maximizing Learning
Background/Purpose: Subspecialty fellows may play an important role in Internal Medicine (IM) residents’ education and career specialty choice (Horn 2008). This may be particularly important…Abstract Number: 2815 • 2013 ACR/ARHP Annual Meeting
Preliminary Entrustable Professional Activities in Muscloskeletal Ultrasound For Rheumatology Fellowship Training
Preliminary Entrustable Professional Activities in Muscloskeletal Ultrasound for Rheumatology Fellowship Training Background/Purpose: As part of the Next Accreditation System (NAS), the Accreditation Council for Graduate…Abstract Number: 2776 • 2013 ACR/ARHP Annual Meeting
Ankylosing Spondylitis Is Associated With An Increased Likelihood Of Cardiovascular Disease: A Nationwide Matched Cohort Study In Primary Care
Background/Purpose: Cardiovascular disease (CVD) risk is well established in rheumatoid arthritis but less so in ankylosing spondylitis (AS). Due to a similar inflammatory profile, AS…Abstract Number: 2777 • 2013 ACR/ARHP Annual Meeting
Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: Part of a Common Spectrum Or Distinct Diseases? Analysis of a Longitudinal Prospective Cohort
Ankylosing spondylitis and non-radiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? Analysis of a longitudinal prospective cohort. Background/Purpose: Historically ankylosing spondylitis…Abstract Number: 2778 • 2013 ACR/ARHP Annual Meeting
Mortality In United States Veterans With The HLA-B27 Gene
Background/Purpose : HLA-B27 (B27) is carried by in 6-8% of Americans and is strongly associated with spondyloarthritis (SpA). SpA has been associated with premature mortality.…Abstract Number: 2779 • 2013 ACR/ARHP Annual Meeting
A Novel Evidence-Based Detection Of Undiagnosed Spondyloarthritis In Patients Presenting With Acute Anterior Uveitis: The DUET (Dublin Uveitis Evaluation Tool) Algorithm
Background/Purpose: The prevalence of mostly undiagnosed underlying Spondyloarthropathy (SpA) is more than 60% among patients presenting with acute anterior uveitis (AAU). To date, there are…
ACR Meeting Abstracts